Loss of huntingtin function slows synaptic vesicle endocytosis in striatal neurons from the httQ140/Q140 mouse model of Huntington's disease - PubMed (original) (raw)

Loss of huntingtin function slows synaptic vesicle endocytosis in striatal neurons from the httQ140/Q140 mouse model of Huntington's disease

Robyn L McAdam et al. Neurobiol Dis. 2020 Feb.

Free article

Abstract

Huntington's disease (HD) is caused by CAG repeat expansion within the HTT gene, with the dysfunction and eventual loss of striatal medium spiny neurons a notable feature. Since medium spiny neurons receive high amounts of synaptic input, we hypothesised that this vulnerability originates from an inability to sustain presynaptic performance during intense neuronal activity. To test this hypothesis, primary cultures of either hippocampal or striatal neurons were prepared from either wild-type mice or a knock-in HD mouse model which contains 140 poly-glutamine repeats in the huntingtin protein (httQ140/Q140). We identified a striatum-specific defect in synaptic vesicle (SV) endocytosis in httQ140/Q140 neurons that was only revealed during high frequency stimulation. This dysfunction was also present in neurons that were heterozygous for the mutant HTT allele. Depletion of endogenous huntingtin using hydrophobically-modified siRNA recapitulated this activity-dependent defect in wild-type neurons, whereas depletion of mutant huntingtin did not rescue the effect in httQ140/Q140 neurons. Importantly, this SV endocytosis defect was corrected by overexpression of wild-type huntingtin in homozygous httQ140/Q140 neurons. Therefore, we have identified an activity-dependent and striatum-specific signature of presynaptic dysfunction in neurons derived from pre-symptomatic HD mice, which is due to loss of wild-type huntingtin function. This presynaptic defect may render this specific neuronal subtype unable to operate efficiently during high frequency activity patterns, potentially resulting in dysfunctional neurotransmission, synapse failure and ultimately degeneration.

Keywords: Clathrin; Endocytosis; Endosome; Huntington's disease; Neurodegeneration; Neuron; Synapse; Vesicle.

PubMed Disclaimer

Cited by

Huntington's Disease: Complex Pathogenesis and Therapeutic Strategies.
Tong H, Yang T, Xu S, Li X, Liu L, Zhou G, Yang S, Yin S, Li XJ, Li S. Tong H, et al. Int J Mol Sci. 2024 Mar 29;25(7):3845. doi: 10.3390/ijms25073845. Int J Mol Sci. 2024. PMID: 38612657 Free PMC article. Review.
Molecular Pathophysiological Mechanisms in Huntington's Disease.
Jurcau A. Jurcau A. Biomedicines. 2022 Jun 17;10(6):1432. doi: 10.3390/biomedicines10061432. Biomedicines. 2022. PMID: 35740453 Free PMC article. Review.
Potential of Therapeutic Small Molecules in Apoptosis Regulation in the Treatment of Neurodegenerative Diseases: An Updated Review.
Dailah HG. Dailah HG. Molecules. 2022 Oct 25;27(21):7207. doi: 10.3390/molecules27217207. Molecules. 2022. PMID: 36364033 Free PMC article. Review.
Acetylation State of Lysine 14 of Histone H3.3 Affects Mutant Huntingtin Induced Pathogenesis.
Faragó A, Zsindely N, Farkas A, Neller A, Siági F, Szabó MR, Csont T, Bodai L. Faragó A, et al. Int J Mol Sci. 2022 Dec 2;23(23):15173. doi: 10.3390/ijms232315173. Int J Mol Sci. 2022. PMID: 36499499 Free PMC article.
Brain-Derived Neurotrophic Factor Dysregulation as an Essential Pathological Feature in Huntington's Disease: Mechanisms and Potential Therapeutics.
Speidell A, Bin Abid N, Yano H. Speidell A, et al. Biomedicines. 2023 Aug 16;11(8):2275. doi: 10.3390/biomedicines11082275. Biomedicines. 2023. PMID: 37626771 Free PMC article. Review.

Loss of huntingtin function slows synaptic vesicle endocytosis in striatal neurons from the httQ140/Q140 mouse model of Huntington's disease - PubMed (original) (raw)